{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/briefvertex-announces-reimbursement-of-cystic-fibrosis-medicines-symdeko-and-orkambi-with-certain-cftr-mutations-in-australia-1975312", "downloaded_at": "2019-10-20 03:38:24.028705+00:00", "title": "BRIEF-Vertex Announces Reimbursement Of Cystic Fibrosis Medicines Symdeko And Orkambi With Certain CFTR Mutations in Australia", "language": "en", "text": "BRIEF-Vertex Announces Reimbursement Of Cystic Fibrosis Medicines Symdeko And Orkambi With Certain CFTR Mutations in Australia\n\nStock Markets 24 minutes ago (Oct 20, 2019 14:14)\n\n\u00a9 Reuters. BRIEF-Vertex Announces Reimbursement Of Cystic Fibrosis Medicines Symdeko And Orkambi With Certain CFTR Mutations in Australia Oct 19 (Reuters) - Vertex Pharmaceuticals Inc : * VERTEX ANNOUNCES REIMBURSEMENT OF CYSTIC FIBROSIS MEDICINES SYMDEKO AND ORKAMBI, WITH CERTAIN CFTR MUTATIONS IN AUSTRALIA\n\nBRIEF-Vertex Announces Reimbursement Of Cystic Fibrosis Medicines Symdeko And Orkambi With Certain CFTR Mutations in Australia", "description": "BRIEF-Vertex Announces Reimbursement Of Cystic Fibrosis Medicines Symdeko And Orkambi With Certain CFTR Mutations in Australia", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB65083_L.jpg", "published_at": "2019-10-20"}